Vision Ophthalmology Group becomes AddVision
Vision Ophthalmology Group, Europe’s leading independent ophthalmic solutions partner, changes its name to AddVision and launches a new visual identity.
“We continue to add new suppliers and expand our customer base throughout Europe. With our new name and visual identity, it will be clearer to all our stakeholders that we are one unified network and a strong partner to the medical community,” says Dr. Dario Aganovic, CEO of AddVision.
AddVision currently consists of six companies, Spectrum, Polytech Domilens, Medilas, Polymed Polska, M.E.D Medical products and Polytech. The group leverages its strength by building central functions for Product Management and International Key Accounts, in addition to shared services, such as Finance, IT, HR and Regulatory Affairs. The local companies will keep their current names and share the same visual identity and symbol. “This reinforces how AddVision combines the larger company’s strength with the local company’s closeness to customers and entrepreneurial culture,” explains Dr. Aganovic. “Our customers and trusted suppliers will continue to feel right at home, but with a range of added opportunities on both ends.”
Improved outcomes and enhanced reach
AddVision acts independently of large multinational corporations, allowing surgeons and clinics to choose what is best for them. Direct access to preferred products and solutions, innovations, training, and support enables better and more efficient patient care. And for suppliers and strategic partners, who meet our rigorous quality standards, our vast networks provide access to the entire European market and beyond.
Bringing greater vision to everyone
As a leading partner, we bring innovative development to European markets, always offering the right ophthalmic solutions, tailored for the specific needs of patients, clinics, and hospitals – bringing greater vision to everyone. This is expressed in our shared symbol, a simplified eye that is open to the world, new opportunities, and innovations with the potential of helping millions of people regain or improve sight and a new outlook on life.
For more information contact Dario Aganovic, Group CEO
+46 72555 11 01